Discover
RGNT
Regentis Biomaterials Ltd.
1.81
100 x undefined
100 x undefined
bid
ask
+
0.06
3.43%
1 @ 04:00 AM
1.85 +0.04 (2.21%)
| Ytd | -73.15% | |
| 1y | -75.87% |
1.73
day range
1.88
1.23
52 week range
15.50
| Open | 1.80 | Prev Close | 1.75 | Low | 1.73 | High | 1.88 | Mkt Cap | 12.71M |
| Vol | 22.81K | Avg Vol | 125.55K | EPS | -23.94 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.06 | 200-d Avg | 3.66 | 1yr Est | 0.00 |
RGNT News
globenewswire.com
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Ehud Geller, CEO of Regentis Bi
AUSTIN, Texas, Sept. 18, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organ
benzinga.com
Regentis Biomaterials H1 EPS $(0.44) Up From $(1.17) YoY
Regentis Biomaterials (AMEX:RGNT) reported quarterly losses of $(0.44) per share. This is a 62.39 pe